Journal of Immunology Research

Cancer Immunology and Cancer Immunodiagnosis


Publishing date
01 Aug 2014
Status
Published
Submission deadline
14 Mar 2014

Lead Editor

1Cancer Autoimmunity Research Laboratory, Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA

2Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiao Tong University Medical Center, Shaanxi, China

3Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

4Center for Tumor Biotherapy & Department of Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China


Cancer Immunology and Cancer Immunodiagnosis

Description

Cancer immunology is the study of interactions between the immune system and cancer cells, which is a growing field of research that aims to identify biomarkers in cancer immunodiagnosis and to discover innovative cancer immunotherapies. The immune response, including the recognition of cancer-specific antigens, is of particular interest in cancer immunology field as the knowledge gained drives the development of new vaccines and antibody therapies. It is also well demonstrated that the immune system can recognize the antigenic changes in cancer cell and further develop antibody against these cellular antigens that have been generally called tumor-associated antigens (TAAs). These cancer-associated autoantibodies might be considered as “reporters” from the immune system to identify the antigenic changes in cellular proteins involved in the transformation process. There has been a growing interest in using serum autoantibodies against TAAs as biomarkers in cancer immunodiagnosis. The persistence and stability of these antibodies in the serum of cancer patients is an advantage over other potential markers, including the TAAs themselves, some of which are released by tumors but rapidly are degraded or cleared after circulating in the serum for a limited time. The key to cancer immunodiagnosis and immunotherapy is an improved understanding of the immune response during malignant transformation.

We invite investigators to contribute original research articles as well as review articles related to cancer immunology. We are particularly interested in articles describing cancer immunodiagnosis and cancer immunotherapy. Both laboratory and clinical studies are welcome. Potential topics include, but not limited to:

  • Recent advances in cancer immunology, cancer immunodiagnosis, and cancer immunotherapy
  • Evaluation and validation of TAAs and anti-TAAs as biomarkers in cancer immunodiagnosis
  • Identification and characterization of tumor antigens as potential candidates in cancer vaccine development or as potential targets in cancer immunotherapy
  • Basic studies of tumor antigens involved in tumorigenesis
  • Clinical studies with relevance to cancer immunology and immunodiagnosis

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jir/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jir/cici/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 725691
  • - Editorial

Cancer Immunology and Cancer Immunodiagnosis

Jianying Zhang | Suxia Han | ... | Yi Zhang
  • Special Issue
  • - Volume 2014
  • - Article ID 849720
  • - Review Article

The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets

M. Isabel Palacios-Arreola | Karen E. Nava-Castro | ... | Jorge Morales-Montor
  • Special Issue
  • - Volume 2014
  • - Article ID 574981
  • - Review Article

Use of Autoantibodies to Detect the Onset of Breast Cancer

Jérôme Lacombe | Alain Mangé | Jérôme Solassol
  • Special Issue
  • - Volume 2014
  • - Article ID 131494
  • - Research Article

Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma

Zhe Bao Wu | Chao Qiu | ... | Liang Fu Zhou
  • Special Issue
  • - Volume 2014
  • - Article ID 349546
  • - Research Article

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer

Se Ik Kim | Hee Seung Kim | ... | Yong Sang Song
  • Special Issue
  • - Volume 2014
  • - Article ID 492849
  • - Research Article

Hsp74, a Potential Bladder Cancer Marker, Has Direct Interaction with Keratin 1

Ling Chen | YaRong Wang | ... | Xu Li
  • Special Issue
  • - Volume 2014
  • - Article ID 326545
  • - Review Article

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy

Dong-Sup Chung | Hye-Jin Shin | Yong-Kil Hong
  • Special Issue
  • - Volume 2014
  • - Article ID 215471
  • - Review Article

The Roles of Regulatory B Cells in Cancer

Yan He | Hongyan Qian | ... | Guixiu Shi
  • Special Issue
  • - Volume 2014
  • - Article ID 318098
  • - Research Article

IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway

Xinyuan Yang | Jingchun Du | ... | Wu Song
  • Special Issue
  • - Volume 2014
  • - Article ID 794249
  • - Clinical Study

The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance

Jin-lu Ma | Long Jin | ... | Su-xia Han
Journal of Immunology Research
 Journal metrics
Acceptance rate45%
Submission to final decision61 days
Acceptance to publication37 days
CiteScore5.100
Impact Factor3.327
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.